Stock page
CoLabs IntL Corp (CLLB)
CoLabs IntL Corp is a mid-stage biotechnology company that develops products that prevent drugs from being absorbed into the skin and into the environment. Its technology places OTC drugs, pharmaceuticals, and chemicals into encapsulation, limits unwanted absorption of chemicals, drugs, and cosmetics through the skin; and provides a designed release of active ingredients with a prescribed depth of skin penetration.
Quote snapshot
$0.00
Daily change: —
ExchangeNAS
Updated2026-05-09T04:25:51.975162Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|